Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1316 Triple Negative Breast Neoplasms 233 Ovarian Neoplasms 115 Carcinoma, Non-Small-Cell Lung 89 Colorectal Neoplasms 86 Neoplasm Metastasis 83 Prostatic Neoplasms 79 Neoplasms 76 Lung Neoplasms 70 Melanoma 57 Pancreatic Neoplasms 54 Endometrial Neoplasms 54 Stomach Neoplasms 49 Uterine Cervical Neoplasms 44 Carcinoma, Intraductal, Noninfiltrating 41 Squamous Cell Carcinoma of Head and Neck 38 Colonic Neoplasms 37 Head and Neck Neoplasms 33 Carcinoma, Renal Cell 33 Esophageal Neoplasms 27 Breast Carcinoma In Situ 27 Small Cell Lung Carcinoma 25 Sarcoma 25 Brain Neoplasms 25 Urinary Bladder Neoplasms 22 Anatomic Stage I Breast Cancer AJCC v8 22 Carcinoma, Transitional Cell 20 Advanced Breast Cancer 18 Liver Neoplasms 17 Gastrointestinal Neoplasms 17

Interventions

ribociclib 1 Letrozole 1 Goserelin 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Breast × 90 days × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡